Yang, Ni
Ma, Teng http://orcid.org/0000-0003-3828-454X
Xie, Yong
Li, Qiong
Li, Yingmeng
Zheng, Longjin
Li, Yalin
Xiao, Qiuping
Sun, Zhihong http://orcid.org/0000-0002-7605-2048
Zuo, Kexuan
Kwok, Lai-Yu http://orcid.org/0000-0001-8791-1269
Lu, Nonghua
Liu, Wenjun
Zhang, Heping
Article History
Received: 10 May 2023
Accepted: 29 July 2024
First Online: 9 August 2024
Competing interests
: The authors declare no competing interests.
: This was a comprehensive randomized, double-blind, placebo-controlled study conducted in collaboration with the First Affiliated Hospital of Nanchang University from October 2020 to May 2021. The study was registered at the Chinese Clinical Trial Registry under the registration number ChiCTR2000038410 () and approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University (No. IIT [2020] Clinical Ethics Review No. 002).
: Informed consent was required from all subjects prior to their participation.